Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1508-2025

Boppli: Bedside Device Kit, REF: 54-0002; Sensor Band, REF: 51-0007 Recall

Boppli: Bedside Device Kit, REF: 54-0002; Sensor Band, REF: 51-0007

FDA recall Class II

Ongoing

FDA lists this Class II recall for Boppli: Bedside Device Kit, REF: 54-0002; Sensor Band, REF: 51-0007. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1508-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 24, 2025
FDA report date
Apr 9, 2025
Quantity in commerce
35
Distribution
See key details
FDA cause
Software design

What is being recalled?

Boppli: Bedside Device Kit, REF: 54-0002; Sensor Band, REF: 51-0007

Affected model & UDI checker

Search the exact identifiers published for Z-1508-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
54-0002Boppli: Bedside Device Kit, REF: 54-0002; Sensor Band, REF: 51-0007Check source noticeNot specified
51-0007Boppli: Bedside Device Kit, REF: 54-0002; Sensor Band, REF: 51-0007Check source noticeNot specified
FDA code information

Software version: 2.2.3 Part/UFI-DI/Lot: 54-0002/10860007282925/24020902, 24040302, 23103002; 51-0007/10860007282901/24011702, 24111301

View the original FDA recall notice

Why was this product recalled?

Single-use battery-powered blood pressure monitor, for use on neonates and infants, due to vibratory noise, may not adequately detect changes in blood pressure per specification. Containment actions: 1) Ventilator lines not to touch the isolette (e.g. mattress, side rails, pillow) or patient, 2) Move affected monitor to patient's foot.

What actions did PYRAMES INC take?

The firm sent a MEDICAL DEVICE CORRECTIONS NOTTICE" dated 3/5/2025 to its customers describing the product, problem and actions to be taken. Starting on 2/24/2025, the firm started providing training to users to inform them of the following: Signal may be green, but high frequency noise appears superimposed on pulse waveform signal. Containment actions: 1) Ensure that ventilator lines do not physically touch the isolette (e.g. mattress, side rails, pillow) or baby. 2) Move Boppli to patient's foot. On 3/7/2025, correction notices were emailed to customers who in addition to the above were asked to do the following: 3) Use cuff measurement(s) to confirm that the signal is no longer affected by the high-frequency oscillatory ventilation (HFOV) interference. 4) Share this notice with anyone who needs to be made aware within the organization and forward to any organization where potentially affected devices have been transferred. 5) If these actions do not mitigate the issue, discontinue using the affected blood pressure monitoring device. Firm will be releasing a new version of software that will recognize the HFOV interference, indicate its presence by changing the signal color to red, and exclude that data from BP calculations. It is expected that this solution will be implemented by April 30, 2025. The Instructions for Use (55-0001 Rev. E) was updated to include warnings of vibratory interference, what it looks like and what to do when it is identified. Please contact support@pyrameshealth.com or 408-569-5215 for further information.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology